Author

C. K. Harms

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

H. F. Moffett· 1 shared J. Boonyaratankornkit· 1 shared J. J. Taylor· 1 shared K. S. Fitzpatrick· 1 shared M. R. Tooley· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

H. F. Moffett

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

B cells engineered to express pathogen-specific antibodies using CRISPR/Cas9 protect against infection

H. F. Moffett, C. K. Harms, K. S. Fitzpatrick, M. R. Tooley, J. Boonyaratankornkit, J. J. Taylor

This study uses CRISPR/Cas9 to engineer B cells with pathogen-specific antibodies, providing durable protection against RSV in immunocompromised hosts.

bioRxiv · Feb 6, 2019Immunology